infection

04/22/2014 - 09:13

When humans are suffering from an infection, it is common to become fatigued and to want to sleep more than usual. Two studies on fruit flies published online ahead of print in the journal Sleep suggest that this instinct should be followed. The studies from researchers in the University of Pennsylvania show that sleep is important in increasing resistance to infection and promoting survival.

 

04/09/2014 - 21:02

According to a new study size of foot ulcer in type 2 diabetes patients was significantly reduced following treatment with resveratrol.

 

04/03/2014 - 12:28

New research suggests that drugs commonly used to prevent organ rejection after transplantation may also be helpful for combating HIV. The findings, which are published in the American Journal of Transplantation, suggest a new strategy in the fight against HIV and AIDS.

 

03/25/2014 - 08:10

Like other areas of the body previously thought of as sterile, the female breast harbours a unique microbiome or population of bacteria. Both beneficial and pathogenic bacteria are present and there are preliminary indications that that the levels of E. coli may be higher in cancerous breasts. These are the main findings of a new study published ahead of print in Applied and Environmental Microbiology from researchers in Canada and Ireland.

 

03/13/2014 - 11:07

Some commonly used drugs that combat aches and pains, fever, and inflammation are also thought to have the ability to kill bacteria. New research appearing online on March 13 in the Cell Press journal Chemistry & Biology reveals that these drugs, better known as NSAIDs, act on bacteria in a way that is fundamentally different from current antibiotics. The discovery could open up new strategies for fighting drug-resistant infections and ”superbugs.”

 

03/04/2014 - 12:10

Using technologies and computational modeling that trace the destiny of single cells, researchers at the University of California, San Diego School of Medicine describe for the first time the earliest stages of fate determination among white blood cells called T lymphocytes, providing new insights that may help drug developers create more effective, longer-lasting vaccines against microbial pathogens or cancer.